StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$32.88−0.44 (-1.32%)

Close on Nov 13, 2026Market cap $1.10BP/E –Yield –

SpyGlass Pharma statistics

55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 25, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.10B
$498.53M
Enterprise Value
$891.08M
$433.11M
PB Ratio
5.23
3.24
P/TBV Ratio
5.23
4.81

Share statisticsIndustry

Shares Change (QoQ)
0.03%
0.20%
Float
11M
37M
Shares Held by Insiders
66.8%
10.5%
Shares Held by Institutions
78.1%
60.5%

Short sellingIndustry

Short Interest
1M
–
Short Interest Change
-5.21%
-2.57%
Short % of Float
10.5%
5.11%
Short % of Shares Outstanding
3.47%
3.98%
Days to Cover
12.05
3.94

Stock price statisticsIndustry

20-Day Moving Average
$32.04
–
50-Day Moving Average
$28.78
–
Average True Range (14)
$2.20
–
Price Change (1 Week)
-11.0%
0.99%
Price Change (1 Month)
33.0%
-3.52%
Price Change (3 Months)
27.5%
-7.86%
Price Change (6 Months)
41.7%
-1.12%
Average Volume (10 Days)
128,153
–
Average Volume (20 Days)
114,436
–
Average Volume (90 Days)
107,641
–
Relative Volume
0.36
0.76
Relative Strength Index (14)
55.0
46.7
Volatility (1 Year)
62.4%
64.2%

Returns on capitalIndustry

Return on Equity (ROE)
-114.4%
-17.3%
Return on Assets (ROA)
-31.1%
-12.3%
Return on Capital Employed (ROCE)
-36.4%
-8.13%

Financial positionIndustry

Current Ratio
15.24
2.49
Quick Ratio
14.60
1.53

EfficiencyIndustry

Profits Per Employee
-$1.08M
-$46.47K
Employee Count
65
193

Income statement (TTM)Industry

Operating Income
-$77.25M
-$3.72M
Pretax Income
-$70.49M
-$1.83M
Net Income
-$70.49M
-$6.19M
EBITDA
-$77.25M
-$1.98M
EPS (Diluted)
-$7.73
-$0.11

Balance sheetIndustry

Net Cash (Debt)
$208.69M
$3.95M
Net Cash Per Share
$6.24
$0.26
Equity (Book Value)
$210.44M
$63.80M
Book Value Per Share
$6.29
$3.26
Tangible Book Value
$210.44M
$11.61M
Working Capital
$203.62M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
-$53.74M
-$483.87K
Capital Expenditures
-$5.49M
-$3.94M
Free Cash Flow
-$59.23M
-$238.00K
FCF Per Share
-$1.77
-$0.00

Dividends and yieldsIndustry

Earnings Yield
-6.41%
-4.76%
FCF Yield
-5.39%
0.28%

Taxes and interestIndustry

Income Tax
$0
$1.55M

Scores and fair valueIndustry

Altman Z-Score
40.43
2.47
Piotroski F-Score
4
5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodSGPS&P 500DifferenceSGP per yearS&P 500 per year
1 month+37.5%-3.0%+40.5 pts
3 months+30.6%-2.8%+33.4 pts
Year to date+16.8%+11.5%+5.3 pts
1 year+16.8%+13.5%+3.3 pts
3 years+16.8%+77.7%−60.9 pts+5.3%+21.1%
5 years+16.8%+72.6%−55.8 pts+3.2%+11.5%
10 years+16.8%+308.2%−291.4 pts+1.6%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M SGP shares were sold short on Oct 30, 2026, down 5.2% from the previous report, or 10.45% of the shares available to trade. At recent volumes it would take 12.1 days to buy them back. Over the last 20 sessions, 47.4% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,160,601-5.2%96,34312.1
Oct 15, 20261,224,357-2.3%78,21715.7
Sep 30, 20261,253,724+2.0%176,3587.1
Sep 15, 20261,229,711+12.1%105,64811.6
Aug 31, 20261,096,948-3.5%69,54415.8
Aug 14, 20261,136,810-0.3%74,58815.2
Jul 31, 20261,140,494+0.9%94,55312.1
Jul 15, 20261,130,776-13.7%142,3437.9
Jun 30, 20261,310,944+29.5%238,2715.5
Jun 15, 20261,012,004-11.6%70,78614.3
May 29, 20261,144,420+33.3%58,85819.4
May 15, 2026858,550-2.9%62,31913.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?